EXHIBIT 31.1

                                  CERTIFICATION

         I, James H. Kelly, certify that:

         1.       I have reviewed this  quarterly  report on Form 10-QSB of Stem
Cell Innovations, Inc.;

         2.       Based on my knowledge,  this quarterly report does not contain
any  untrue  statement  of a  material  fact or omit to  state a  material  fact
necessary to make the statements made, in light of the circumstances under which
such  statements were made, not misleading with respect to the period covered by
this quarterly report;

         3.       Based on my  knowledge,  the financial  statements,  and other
financial  information included in this quarterly report,  fairly present in all
material respects the financial condition,  results of operations and cash flows
of the  registrant  as of, and for,  the  periods  presented  in this  quarterly
report;

         4.       I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for
the registrant and have:

                  a)       designed such  disclosure  controls and procedures to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

                  b)       evaluated  the   effectiveness  of  the  registrant's
disclosure  controls  and  procedures  as of a date  within 90 days prior to the
filing date of this quarterly report (the "Evaluation Date"); and

                  c)       presented in this  quarterly  report our  conclusions
about the  effectiveness of the disclosure  controls and procedures based on our
evaluation as of the Evaluation Date;

         I  have  disclosed,   based  on  my  most  recent  evaluation,  to  the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

                  a)       all   significant   deficiencies  in  the  design  or
operation of internal  controls which could  adversely  affect the  registrant's
ability  to  record,  process,  summarize  and  report  financial  data and have
identified  for the  registrant's  auditors any material  weaknesses in internal
controls; and

                  b.       any fraud, whether or not material, that involves
management or other  employees who have a significant  role in the  registrant's
internal controls; and

         6.       I have indicated in this quarterly report whether or not there
were  significant  changes in internal  controls or in other  factors that could
significantly  affect internal controls subsequent to the date of my most recent
evaluation,   including  any  corrective  actions  with  regard  to  significant
deficiencies and material weaknesses.

Date:  August 14, 2007
                                                     /s/ Dr. James H. Kelly
                                                     ---------------------------
                                                     Chief Executive Officer
                                                     and Chief Financial Officer

                                       24